Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial
Rami Kantor(Johns Hopkins University Center for AIDS Research), Susan H. Eshleman(Johns Hopkins University), Mina C. Hosseinipour, Breno Santos(Hospital Nossa Senhora da Conceição), Shanmugam Saravanan(YR Gaitonde Centre for AIDS Research and Education), Thomas Campbell(University of Colorado Anschutz Medical Campus), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Khuanchai Supparatpinyo(Chiang Mai University), Mohammed Rassool(Helen Joseph Hospital), Johnstone Kumwenda(Blantyre Institute for Community Ophthalmology), John W. Mellors(Textron Systems (United Kingdom)), Srikanth Tripathy(Indian Council of Medical Research), Elias K. Halvas(University of Pittsburgh), Marissa B Reitsma(Stanford University), Umesh Lalloo(Wentworth Hospital), Timothy Flanigan(Brown University), Pachamuthu Balakrishnan(YR Gaitonde Centre for AIDS Research and Education), Saran Vardhanabhuti, Mariza Gonçalves Morgado(Fundação Oswaldo Cruz), Stephen A. Hart(Nationwide Children's Hospital), Laura Smeaton(Cancer Research And Biostatistics), Carole L. Wallis, Nagalingeswaran Kumarasamy(University of North Carolina at Chapel Hill), Alberto La Rosa(Asociación Civil Impacta Salud y Educación), Sarah E. Hudelson(Johns Hopkins University), James Hakim(University of Zimbabwe), Javier R. Lama(Asociación Civil Impacta Salud y Educación)
Cited by 80
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015
|The Lancet|2017|2.1k
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k